lysergic acid diethylamide has been researched along with Cardiac Death in 3 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jing, X | 1 |
| Hoeh, NR | 1 |
| Menkes, DB | 1 |
| Schulz, R | 1 |
| Kast, E | 1 |
1 review available for lysergic acid diethylamide and Cardiac Death
| Article | Year |
|---|---|
Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.
Topics: Death; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Terminal Care | 2023 |
2 other studies available for lysergic acid diethylamide and Cardiac Death
| Article | Year |
|---|---|
Meeting the three major needs of the dying patient.
Topics: Cannabis; Death; Environment; Ethanol; Humans; Love; Lysergic Acid Diethylamide; Palliative Care; Ph | 1976 |
LSD and the dying patient.
Topics: Chlorpromazine; Death; Humans; Lysergic Acid Diethylamide; Neoplasms; Palliative Care | 1966 |